Business Standard

Tuesday, December 24, 2024 | 06:46 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's gains 6% in two days post clarification on regulatory issues

The stock moved higher by 3% to Rs 2,473, extending its Thursday's 3% gain on BSE.

Torrent Pharma, Pharma
Premium

Torrent Pharma, Pharma

SI Reporter Mumbai
Dr Reddy’s Laboratories moved higher by 3% to Rs 2,473, extending its Thursday’s 3% gain on BSE, after the company clarified that it has no updates regarding the establishment inspection report (EIR) for Duvvada facility. The stock is trading at its highest level since November 21, 2017 on BSE.

On Wednesday, January 3, the stock had dipped 3% on the buzz of issues raised in EIR for Duvvada plant.

"The company has already intimated the stock exchanges on November 21, 2017 regarding the updated status of US Food and Drug Administration (USFDA) audit of our formulations manufacturing facility

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in